ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it will host a conference call and live webcast on Tuesday, August 12, 2025, at 8:30 a.m. EDT to report financial results for the second quarter of 2025 and provide operational updates. https://mma.prnewswire.com/media/2543351/ADC_Therapeutics_SA__logo.jpg […]